rss
Evid Based Nurs 10:78 doi:10.1136/ebn.10.3.78
  • Treatment

Review: lifestyle or pharmacological interventions prevent or delay type 2 diabetes in people with impaired glucose tolerance

Lifestyle or pharmacological interventions v placebo to prevent or delay type 2 diabetes in people with impaired glucose tolerance*

Outcome at mean 0.4–4.6 y Comparisons Number of trials (n) Hazard ratio (95% CI) NNT (credible interval)
*Abbreviations defined in glossary.
†Lifestyle interventions included diet, exercise, or both.
‡Oral diabetes drugs were acarbose, flumamine, glipizide, metformin, or phenformin.
Type 2 diabetes Lifestyle v placebo† 10 (4452) 0.51 (0.44 to 0.60) 7 (5 to 9)
Oral diabetes drug v placebo‡ 8 (4580) 0.70 (0.62 to 0.79) 11 (9 to 15)
Orlistat v placebo 2 (814) 0.44 (0.28 to 0.69) 6 (5 to 8)
Jiangtang bushen v placebo 1 (51) 0.32 (0.03 to 3.07) Not significant

This Article

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article